Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC)

NCT03669822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2025-01-24

No results posted yet for this study

Summary

Ulcerative colitis (UC) is a chronic, progressive immunologically mediated disease affecting nearly 1 million Americans. Up to one third of patients with UC will require hospitalization for severe disease (termed 'acute severe colitis (ASUC)'), often within the first year after diagnosis. Investigators will develop a large multi-center cohort of patients with ASUC with homogeneously collected detailed longitudinal clinical and laboratory data.

Conditions

Interventions

OTHER

Standard of care

Care decisions driven by local physicians; this is an observational cohort.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669822 on ClinicalTrials.gov